» Articles » PMID: 20142102

FoxO1 is a Positive Regulator of Bone Formation by Favoring Protein Synthesis and Resistance to Oxidative Stress in Osteoblasts

Overview
Journal Cell Metab
Publisher Cell Press
Date 2010 Feb 10
PMID 20142102
Citations 176
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoporosis, a disease of low bone mass, is associated with decreased osteoblast numbers and increased levels of oxidative stress within osteoblasts. Since transcription factors of the FoxO family confer stress resistance, we investigated their potential impact on skeletal integrity. Here we employ cell-specific deletion and molecular analyses to show that, among the three FoxO proteins, only FoxO1 is required for proliferation and redox balance in osteoblasts and thereby controls bone formation. FoxO1 regulation of osteoblast proliferation occurs through its interaction with ATF4, a transcription factor regulating amino acid import, as well as through its regulation of a stress-dependent pathway influencing p53 signaling. Accordingly, decreasing oxidative stress levels or increasing protein intake normalizes bone formation and bone mass in mice lacking FoxO1 specifically in osteoblasts. These results identify FoxO1 as a crucial regulator of osteoblast physiology and provide a direct mechanistic link between oxidative stress and the regulation of bone remodeling.

Citing Articles

Protective Effect of Methyl Sulfonyl Methane on the Progression of Age-Induced Bone Loss by Regulating Oxidative Stress-Mediated Bone Resorption.

Zhang D, Wang L, Tang L, Zhang Y, Zhang H, Zou L Antioxidants (Basel). 2025; 14(2).

PMID: 40002402 PMC: 11851857. DOI: 10.3390/antiox14020216.


Identifying Herbal Candidates and Active Ingredients Against Postmenopausal Osteoporosis Using Biased Random Walk on a Multiscale Network.

Jang B, Kim Y, Song J, Kim Y, Lee W Int J Mol Sci. 2024; 25(22).

PMID: 39596387 PMC: 11594441. DOI: 10.3390/ijms252212322.


Decoding senescence of aging single cells at the nexus of biomaterials, microfluidics, and spatial omics.

Venkataraman A, Kordic I, Li J, Zhang N, Bharadwaj N, Fang Z NPJ Aging. 2024; 10(1):57.

PMID: 39592596 PMC: 11599402. DOI: 10.1038/s41514-024-00178-w.


Proteome-wide Mendelian randomization provides novel insights into the pathogenesis and druggable targets of osteoporosis.

Yan J, Huai Y, Liang Q, Lin L, Liao B Front Med (Lausanne). 2024; 11:1426261.

PMID: 39526243 PMC: 11543481. DOI: 10.3389/fmed.2024.1426261.


FOXO1-mTOR pathway in vascular pericyte regulates the formation of type H vessels to control bone metabolism.

Cheng C, Deng M, Cheng C, Wu H, Wang Y, Lu M J Orthop Translat. 2024; 49:246-263.

PMID: 39524152 PMC: 11546805. DOI: 10.1016/j.jot.2024.08.010.


References
1.
Wagner E . Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis. 2002; 61 Suppl 2:ii40-2. PMC: 1766713. DOI: 10.1136/ard.61.suppl_2.ii40. View

2.
Tothova Z, Kollipara R, Huntly B, Lee B, Castrillon D, Cullen D . FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 2007; 128(2):325-39. DOI: 10.1016/j.cell.2007.01.003. View

3.
Harding H, Zhang Y, Zeng H, Novoa I, Lu P, Calfon M . An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell. 2003; 11(3):619-33. DOI: 10.1016/s1097-2765(03)00105-9. View

4.
Almeida M, Han L, Martin-Millan M, Plotkin L, Stewart S, Roberson P . Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 2007; 282(37):27285-27297. PMC: 3119455. DOI: 10.1074/jbc.M702810200. View

5.
Teitelbaum S, Ross F . Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003; 4(8):638-49. DOI: 10.1038/nrg1122. View